The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...
SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...
LS Securities forecasted on the 22nd that sales of Nextbiomedical will rapidly increase as the market penetration rate of NexPowder rises. Jo Eun-ae, a researcher at LS Securities, explained, ...
Next Biomedical announced on the 17th that it has completed the first shipment of its hemostatic agent for endoscopy, Nexpowder, to Japan. Nexpowder received product approval from the Pharmaceuticals ...
The Nexpowder system includes a hand-held spray controller that connects to a catheter. Once the bright blue powder is sprayed onto a bleeding site, it reacts with the blood to form a gel with nearly ...
Nexpowder is a noncontact, nonthermal and nontraumatic powder that can treat upper gastrointestinal bleeding, according to a Sept. 28 news release from the company shared with Becker’s. Seventy-five ...
NextBioMedical has set a new record high since its listing on the KOSDAQ market in August last year. The company’s profitability continued through the third quarter following the second quarter this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results